fibrinogen has been researched along with Wet Macular Degeneration in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bertelmann, T; Hoffmann, J; Husi, H; Jankowski, J; Klein, J; Koch, F; Koss, MJ; Krueger, K; Mischak, H; Mullen, W; Nguyen, N; Pfister, M; Rejdak, R; Schanstra, JP; Siwy, J | 1 |
Losada, M; Manresa, N; Mulero, J; Zafrilla, P | 1 |
2 other study(ies) available for fibrinogen and Wet Macular Degeneration
Article | Year |
---|---|
Proteomics of vitreous humor of patients with exudative age-related macular degeneration.
Topics: Aged; Aged, 80 and over; alpha 1-Antitrypsin; Antibodies, Monoclonal, Humanized; Bevacizumab; Biomarkers; Case-Control Studies; Female; Fibrinogen; Gene Expression Regulation; Humans; Intramolecular Oxidoreductases; Lipocalins; Male; Middle Aged; Peptide Fragments; Proteomics; Steroids; Vitrectomy; Vitreous Body; Wet Macular Degeneration | 2014 |
Influence of anti-VEGF about cardiovascular biomarkers in age related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Atherosclerosis; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Homocysteine; Humans; Lipids; Macular Degeneration; Male; Middle Aged; Ranibizumab; Risk Factors; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2015 |